Thermo Fisher Scientific Stock
Thermo Fisher Scientific Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- United States
- CEO
- Marc N. Casper
- Employees
- 125,000
- Market cap
- $255.1 B
- IPO
- 17/03/1980
Thermo Fisher Scientific Inc. is a global player in the Healthcare / Medical - Diagnostics & Research sector, offering a comprehensive spectrum ranging from life science solutions to analytical precision instruments. Based in the USA and headquartered in Waltham, Massachusetts, the company serves customers in…
AI-generated company profile based on the figures on this page, last updated on 05/08/2026. Not investment advice.
Thermo Fisher Scientific stock: price history
1D
-0.9%
1W
+4.9%
1M
+6.4%
6M
+31.0%
YTD
+19.1%
1Y
+28.5%
2Y
+16.6%
5Y
+18.5%
10Y
+354.8%
Next earnings date
Next earnings date
21/10/2026 (in 4 days)
Volatility around earnings
~42% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vrange-breakout-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Range breakout
BullishThe price has broken out of a longer sideways range (support and resistance) to the upside or downside. In technical analysis, this is read as a signal that a new trend is starting in the breakout direction.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Thermo Fisher Scientific stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 16/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
1 more assignment (Enabler/Second row) Pro-only.
Thermo Fisher Scientific Inc. is a globally operating provider of scientific solutions covering a broad spectrum ranging from highly precise analytical instruments through specialized diagnostics to laboratory consumables and research services. The business model is characterized by a combination of hardware sales and highly recurring revenues from the sale of reagents, consumables, and comprehensive clinical services. By linking specialized equipment with matching consumables, the company achieves strong customer loyalty across various sectors including the pharmaceutical industry, biotechnology, and academia.
- Revenue model
- Mixed
- Recurring revenue
- High
- Pricing power
- Weak
- Moat
- Wide
- Moat type
- Switching costs
- Capital intensity
- High
- Customer concentration
- Low
Ask the agents about Thermo Fisher Scientific
Analyst assessment of Thermo Fisher Scientific
PRICE TARGET LOW
US$520.00
CONSENSUS
US$664.79
MEDIAN
US$685.00
PRICE TARGET HIGH
US$750.00
0
STRONG BUY
36
BUY
7
HOLD
0
SELL
0
STRONG SELL
43
TOTAL · Buy
As of: 13/10/2026
Thermo Fisher Scientific stock metrics
P/E
37.06
P/B
4.86
EV/EBITDA
25.38
RETURN ON EQUITY
3.3%
NET MARGIN
14.5%
DEBT/EQUITY
0.81
DIVIDEND YIELD
0.3%
AS OF
27/06/2026
Free float & liquidity
FREE FLOAT
99.8%
FLOAT SHARES
368,822,918
AVG. DAILY VOLUME (30D)
2,311,533
Insider transactions (SEC)
Shafer Michael D
CASPER MARC N
CASPER MARC N
Meyer James
Meyer James
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -0.9%
Search (Google Trends)
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Thermo Fisher Scientific stock
What does Thermo Fisher Scientific do?
Thermo Fisher Scientific Inc. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Marc N. Casper, the company employs around 125,000 people.
The IPO was on 17/03/1980; the stock trades on NYSE under the ticker TMO.
What do analysts say about Thermo Fisher Scientific stock?
43 analysts rate the stock, the consensus is Buy (as of 13/10/2026).
The average price target is US$664.79, ranging from US$520.00 to US$750.00, with a median of US$685.00.
This is an external assessment, not a statement by Market Jury.
When does Thermo Fisher Scientific report next?
The next earnings date is 21/10/2026.
Around past earnings, price swings were roughly 42% stronger than usual.
Does Thermo Fisher Scientific pay a dividend?
Yes. The last dividend was US$0.47 per share, ex-date 15/09/2026, paid on 15/10/2026.
The dividend yield is 0.3% (as of 27/06/2026).
Which stocks are comparable to Thermo Fisher Scientific?
Comparable stocks include Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina, IDEXX Laboratories and Mettler-Toledo International.
How can I get Thermo Fisher Scientific stock analyzed?
Clicking "Analyze stock" lets five strategies assess Thermo Fisher Scientific against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.